trending Market Intelligence /marketintelligence/en/news-insights/trending/ekHu0idDfgzOgE-k4nkamg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

CTI BioPharma appoints director; 2 board members step down

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


CTI BioPharma appoints director; 2 board members step down

CTI BioPharma Corp. said Phillip Nudelman and Jack Singer resigned as board members.

Their resignations are not due to any disagreement with the company's board or management.

Nudelman stepped down due to health reasons. Singer will remain at CTI BioPharma as executive vice president, chief scientific officer, interim chief medical officer and global head of translational medicine.

Additionally, the company appointed David Parkinson to its board, to serve until the next CTI BioPharma annual shareholder meeting. Parkinson is president and CEO of ESSA Pharma Inc.